AstraZeneca Makes Rare Disease Push
Acquiring Alexion would bolster AstraZeneca in areas such as the treatment of blood disorders.
Use phrases "in quotes" or the tools below to better filter your results.
This is premium content
To read the full story, please upgrade your plan to Gold, Platinum, or Enterprise.
Upgrade plan